Advertisement

Topics

Glaukos Corporation Announces Fourth Quarter & Full Year 2016 Financial Results

16:15 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company Also Provides 2017 Net Sales Guidance Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tr...

Other Sources for this Article

Glaukos Corporation
Sheree Aronson
VP, Investor Relations
(949) 367-9600 ext 371
saronson@glaukos.com

NEXT ARTICLE

More From BioPortfolio on "Glaukos Corporation Announces Fourth Quarter & Full Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...